Complications and prognostic factors in Vogt-Koyanagi-Harada disease. - Test2 - elhamkhani - TriplyDB

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

http://www.wikidata.org/entity/Q43597449

about

Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes Vogt-Koyanagi-Harada syndrome - current perspectives.Current approach in the diagnosis and management of panuveitis.Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome.Headache as an initial manifestation of Vogt-Koyanagi-Harada disease Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease.Pseudotumoral and Multiple Retinal Pigment Epithelium Proliferation in Vogt-Koyanagi-Harada Disease.Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial Association of Vogt Koyanagi Harada Syndrome and Seronegative Rheumatoid Arthritis.Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.Risk of choroidal neovascularization among the uveitides.Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina.Inflammatory choroidal neovascularization.Vogt-Koyanagi-Harada disease in Thailand.Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling.Clinical Characteristics of Inflammatory Choroidal Neovascularization in a Chinese Population.Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.Surgical Treatment of Subretinal Fibrosis Caused Macular Detachment in Vogt-Koyanagi-Harada Disease: A Pioneer Study.The spectrum of Vogt-Koyanagi-Harada disease in Iran.Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases.Vogt-Koyanagi-Harada syndrome presenting with encephalopathy Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome.Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab.Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.Multispectral image analysis in Vogt-Koyanagi-Harada disease.Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome.Vogt-Koyanagi-Harada Disease Chronic Recurrent Vogt–Koyanagi–Harada Disease and Development of ‘Sunset Glow Fundus’ Predict Worse Retinal Sensitivity

P2860

Q26752297-9ECF8F6F-B56E-446D-B972-F2142D7D8711 Q28072882-8E08310C-D709-4133-8499-913AA7E6B732 Q33737954-D5D10F25-CA55-438C-ACA6-1559455F2D82 Q33989519-96E68798-D73F-4CD4-B2CC-E2EC1271D867 Q34051879-FFE7DD67-5F24-4D09-A223-1E47D462E2AE Q34274659-1441792A-83FB-4928-95C8-B49322E3E27A Q35575081-30FF4537-E7EA-4F9C-A00C-573DD913D6ED Q35761981-2782C55B-ABA5-4915-9F81-B9E08D31CB94 Q36174200-B14F2D93-0204-4915-94E3-7FF91EC6C035 Q36291669-D7A926B1-0F7B-4A57-97E4-5FC3F8B0373D Q36722509-0ADE7590-CC5D-4467-AAB8-C67909B6C735 Q36893486-7626CBF6-76E6-4085-9E95-7E0ED2887266 Q36895013-8F414CB7-D435-4E7E-84FA-1A0D27A43875 Q36925622-3C40479E-077E-437F-AD55-3D2142DBBBFF Q37107250-50E29E10-310A-4FF6-A95C-F0815AA8A798 Q37578632-9D062518-27F6-4209-A0AE-670781874229 Q37734236-BE545A55-BE2E-4FB7-8FAD-300B95943109 Q38060844-777DAD40-DD82-4FC8-A409-1600B2C63A36 Q38281318-957A10C8-AE94-424D-B96B-698E4DEFB1DC Q38546629-D52FD2E1-9A9A-4C6B-B181-D6AF9D1389F8 Q38591885-88AC7F67-011C-4932-AC1A-6B5BE9EF0297 Q38919657-68D8434D-1C31-4420-9FFF-59C7EE88A493 Q39161846-5C817A68-8545-4DED-B7C8-ABFE882A26D8 Q39192598-BC1CC71A-6381-41F6-BBB5-22956490E8B9 Q39289618-0C4DCAFC-5485-4BCF-96FB-151CABB6DA1C Q41162044-C7052620-E2DA-49CE-A7A0-F0A9AC4B48A7 Q42027806-7319590E-2BE6-48B7-B9E7-7E292DA2DE25 Q43060158-F51EEB07-74D6-49F6-BF9C-A353C257319C Q43469154-54914C7F-8167-4C08-BE77-676FE0A5E9E3 Q46680282-87CB5B87-1EBF-4259-8E00-9245D9301453 Q48152903-F140F30B-5669-4CDE-B800-17F1E69F8158 Q48241790-FE4E8F0C-0EA2-4455-9A8A-65354508EF27 Q50230399-4592BAC4-6250-4BB7-9002-ED14D9E486CF Q50490823-CFA37806-C89F-46AF-A380-140C52C3B7D5 Q51177631-4A450739-D14B-428C-9C52-47622DEB5DC0 Q53033802-D6482425-A34B-4DE7-A97F-F6531687F8C8 Q53362132-D83FEE87-921B-4E91-AC21-BE9052441F36 Q55982732-CFAE673A-2397-4E86-8FC5-8A69BDE90A80 Q57584157-AA577501-A00C-4438-B651-A890F321A964

P2860

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

http://www.wikidata.org/entity/Q43597449

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@en

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@nl

type

label

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@en

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@nl

prefLabel

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@en

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@nl

P1433

Q43597449-B480EA10-041D-4213-8F66-4F86B346AC58

P1476

Q43597449-8414753E-4CA6-4E28-AEA1-144F4F361A5A

P2093

Q43597449-0BFF5B7B-A1C9-4281-AD7E-F82E0CE91299

Q43597449-2006FE9D-F70F-48C4-AF7E-749A8F7CC1E4

Q43597449-55DB840D-D1BD-4DB7-B5E4-962D4E01CE13

Q43597449-7210BC6D-9A8A-4C25-90DC-F23EBFF8272C

Q43597449-7D9B21B4-0312-4D7E-82B7-7F9C38BE2CE4

Q43597449-899CF42F-ACC3-4043-8D38-1F2639C1FF83

Q43597449-A1EB1754-AB58-4BEB-BFE5-991B1CFFBF87

P304

Q43597449-3FF4A708-FE4F-43CA-B1CD-BB0CC7796358

P31

Q43597449-714E3E9C-D22C-4B4A-98BB-B6FE7D3A43D0

P356

Q43597449-85B3B326-11C7-43DD-BB0B-C521CB7AFB71

P407

Q43597449-299DA012-E110-4643-8DAA-4542CED84757

P433

Q43597449-9A9EA0B6-7F71-4795-B7A8-622C770EC0D4

P478

Q43597449-3725685D-E3AF-4715-9BA3-AAD0F59CE410

P577

Q43597449-D9515F95-A0E6-4087-BA58-3488DA6B8BF9

P698

Q43597449-F1A0C797-703C-4843-870E-C50A1028814E

P356

S0002-9394(01)00937-0

P1433

American Journal of Ophthalmology

P1476

Complications and prognostic factors in Vogt-Koyanagi-Harada disease.

@en

P2093

Butani N

http://www.w3.org/2001/XMLSchema#string

Johnston R

http://www.w3.org/2001/XMLSchema#string

LaBree LD

http://www.w3.org/2001/XMLSchema#string

Rao NA

http://www.w3.org/2001/XMLSchema#string

Read RW

http://www.w3.org/2001/XMLSchema#string

Rechodouni A

http://www.w3.org/2001/XMLSchema#string

Smith RE

http://www.w3.org/2001/XMLSchema#string

P304

599-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9394(01)00937-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11336934

http://www.w3.org/2001/XMLSchema#string